San Francisco startup Composition Therapeutics can be engaged on an oral, the moment-daily GLP-1 drug termed GSBR-1290—the drug surpassed Wall Road’s anticipations in June when a mid-phase research confirmed average weight loss of all-around 6% and it strategies to start out A different mid-stage trial toward the end of the yr—that founder an… Read More